PNV · ASX

Polynovo Limited (ASX:PNV)

AU$1.18

 -0.085 (-6.719%)
ASX:Live
13/06/2025 04:10:38 PM
HALO Small HALO Ords HALO Balance Sheet GROWTH AUS Consensus Cheap +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PNV Overview

PNV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About PNV

Website

Polynovo Limited

Telephone

61.3.8681.4050

Address

Unit 2 320 Lorimer Street Port Melbourne, Victoria (VIC) 3207

Description

Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, Australia and New Zealand, and Other Countries geographical segments. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.

PNV Price Chart

Key Stats

Market Cap

AU$873.92M

PE

357.90

EV/EBITDA

337.7

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.93 - 2.78

Trade Value (12mth)

AU$849,369.00

1 week

-12.27%

1 month

-20.81%

YTD

-42.44%

1 year

-49.57%

All time high

4.08

Key Fundamentals

EPS 3 yr Growth

-208.60%

EBITDA Margin

3.80%

Operating Cashflow

$5m

Free Cash Flow Return

6.20%

ROIC

6.40%

Interest Coverage

5.40

Quick Ratio

3.00

Other Data

Shares on Issue (Fully Dilluted)

700m

HALO Sector

Healthcare

Next Company Report Date

22-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

10.73

PNV Announcements

Latest Announcements

Date Announcements

21 May 25

Becoming a substantial holder

×

Becoming a substantial holder

16 May 25

Investor Presentation & Webcast Link

×

Investor Presentation & Webcast Link

16 May 25

Webcast Recording - Investor Update

×

Webcast Recording - Investor Update

13 May 25

BTM delivers positive First in Man results in Cell Therapies

×

BTM delivers positive First in Man results in Cell Therapies

12 May 25

TGA Clearance for NovoSorb MTX (4 mm and 6 mm)

×

TGA Clearance for NovoSorb MTX (4 mm and 6 mm)

12 May 25

Trading Halt

×

Trading Halt

07 May 25

PolyNovo presents at Macquarie Australia Conference

×

PolyNovo presents at Macquarie Australia Conference

01 May 25

Investor Update Webinar - 16 May 2025

×

Investor Update Webinar - 16 May 2025

22 April 25

Change in substantial holding

×

Change in substantial holding

22 April 25

Change in substantial holding

×

Change in substantial holding

16 April 25

Change in substantial holding

×

Change in substantial holding

14 April 25

Change in Company Secretary

×

Change in Company Secretary

11 April 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

11 April 25

Change in substantial holding

×

Change in substantial holding

09 April 25

First A$11m sales month

×

First A$11m sales month

07 April 25

Change in substantial holding

×

Change in substantial holding

07 April 25

Becoming a substantial holder

×

Becoming a substantial holder

24 March 25

Change in substantial holding

×

Change in substantial holding

19 March 25

NovoSorb MTX product portfolio update

×

NovoSorb MTX product portfolio update

14 March 25

Change in substantial holding

×

Change in substantial holding

13 March 25

Change in substantial holding

×

Change in substantial holding

11 March 25

Change of CEO

×

Change of CEO

07 March 25

Response to article in 'Margin Call'

×

Response to article in 'Margin Call'

07 March 25

Additional response to articles in 'Margin Call'

×

Additional response to articles in 'Margin Call'

27 February 25

Becoming a substantial holder

×

Becoming a substantial holder

25 February 25

Webcast Recording for the 1H FY25 Results Presentation

×

Webcast Recording for the 1H FY25 Results Presentation

PNV Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.01 0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 74.3 -300.0 205.6 Lock Lock Lock
     PE X Lock Lock Lock Lock 1,155.5 13,268.0 357.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.0 379.8 337.7 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6,182.7 56.3 871.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.3 -0.7 0.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.09 0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.09 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.2 277.5 10.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 661 684 700 Lock Lock Lock
Basic m Lock Lock Lock Lock 661 684 690 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 41 65 103 Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.1 57.4 58.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 16 26 35 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 16 19 36 Lock Lock Lock
     Growth % Lock Lock Lock Lock 107.4 19.1 86.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 39.2 29.6 35.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 61 70 65 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 -4 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.9 -353.3 200.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 3.7 -6.0 3.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 2 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 0 -6 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 91.8 -2,309.8 118.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.6 -9.5 1.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -1 -5 2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -1 -5 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 74.1 -312.9 206.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.9 -7.5 5.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -6 5 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 2 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 6 -2 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -5 48 -3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -7 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.2 -192.8 129.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.1 -0.1 0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 47 46 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 35 93 109 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 9 14 13 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 5 -31 -31 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 17 27 37 Lock Lock Lock
Equity $m Lock Lock Lock Lock 18 65 72 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 27 80 85 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.7 195.4 6.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -3.4 -5.3 4.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -6.7 -7.5 7.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -0.8 -11.2 1.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -4.2 -9.3 6.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -7.3 -11.1 6.2 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 4.9 -5.5 5.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.1 7.9 -7.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 27.3 -47.2 -42.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.1 5.3 3.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.7 5.0 3.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 38.3 69.6 58.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -26.5 -46.8 21.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 7.0 6.5 5.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 11.2 13.0 9.9 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 5.0 1.2 1.8 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.5 4.2 6.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.2 0.7 0.9 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.2 0.7 0.9 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -2.8 -7.6 1.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -3.3 -5.3 1.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 -207.5 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -3.4 -5.3 4.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.0 1.4 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -6.7 -7.5 7.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -6.7 -7.5 7.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 32.5 28.1 36.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 51.8 56.3 62.1 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 84.3 84.4 98.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 26.1 17.6 23.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 58.3 66.8 75.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

10.73%

Value ($M)

97

Prior Change

0.10%

7 Day Change

0.10%

1 Month Change

0.30%

3 Month Change

3.70%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PNV Shortsell

Frequently Asked Questions

The current share price of Polynovo Limited (PNV:ASX) is AU$1.18.
The 52-week high share price for Polynovo Limited (PNV:ASX) is AU$2.78.
The 52-week low share price for Polynovo Limited (PNV:ASX)? is AU$0.93.
The current TTM dividend payout for Polynovo Limited (PNV:ASX) is 0.00.
Polynovo Limited (PNV:ASX) does not pay a dividend.
Polynovo Limited (PNV:ASX) has a franking level of 0.0%.
Polynovo Limited (PNV:ASX) is classified in the Healthcare.
The current P/E ratio for Polynovo Limited (PNV:ASX) is 357.90.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.